195 related articles for article (PubMed ID: 35702100)
1. Construction and validation of an eight pyroptosis-related lncRNA risk model for breast cancer.
Tan M; Huang G; Chen J; Yi J; Liu X; Liao N; Hu Y; Zhou W; Guo Q
Am J Transl Res; 2022; 14(5):2779-2800. PubMed ID: 35702100
[TBL] [Abstract][Full Text] [Related]
2. Identification of a pyroptosis-related prognostic signature in breast cancer.
Chen H; Luo H; Wang J; Li J; Jiang Y
BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
[TBL] [Abstract][Full Text] [Related]
3. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
Front Immunol; 2022; 13():854785. PubMed ID: 35392086
[TBL] [Abstract][Full Text] [Related]
4. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
5. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
Lu H; Wu J; Liang L; Wang X; Cai H
Front Immunol; 2022; 13():803355. PubMed ID: 35154117
[TBL] [Abstract][Full Text] [Related]
6. Autophagy related long non-coding RNA and breast cancer prognosis analysis and prognostic risk model establishment.
Luo Z; Nong B; Ma Y; Fang D
Ann Transl Med; 2022 Jan; 10(2):58. PubMed ID: 35282059
[TBL] [Abstract][Full Text] [Related]
7. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer.
Ping L; Zhang K; Ou X; Qiu X; Xiao X
Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734
[No Abstract] [Full Text] [Related]
8. Genome-wide Exploration of a Pyroptosis-Related Long Non-Coding RNA Signature Associated With the Prognosis and Immune Response in Patients With Bladder Cancer.
Gao X; Cai J
Front Genet; 2022; 13():865204. PubMed ID: 35571063
[No Abstract] [Full Text] [Related]
9. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Xiao R; Yang M; Tan Y; Ding R; Li D
Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
[TBL] [Abstract][Full Text] [Related]
10. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
Tan Y; Lu L; Liang X; Chen Y
World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
[TBL] [Abstract][Full Text] [Related]
11. Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer.
Lu Z; Tang F; Li Z; Lai Y; Lu Z; Zhang J; Tang Z; Cai W; He Z
Dis Markers; 2022; 2022():7931393. PubMed ID: 35154513
[TBL] [Abstract][Full Text] [Related]
12. Construction and Validation of Pyroptosis-Related lncRNA Prediction Model for Colon Adenocarcinoma and Immune Infiltration Analysis.
Liu Q; Chen N; Liu L; Zheng Q; Liao W; Zhao M; Zeng J; Tang J
Dis Markers; 2022; 2022():4492608. PubMed ID: 36168326
[TBL] [Abstract][Full Text] [Related]
13. A Prognostic Signature Consisting of Pyroptosis-Related Genes and SCAF11 for Predicting Immune Response in Breast Cancer.
Chu L; Yi Q; Yan Y; Peng J; Li Z; Jiang F; He Q; Ouyang L; Wu S; Fu C; Liu Y; Xu Z
Front Med (Lausanne); 2022; 9():882763. PubMed ID: 35646948
[TBL] [Abstract][Full Text] [Related]
14. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
Wu L; Liu G; He YW; Chen R; Wu ZY
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
[TBL] [Abstract][Full Text] [Related]
15. Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis.
Huang H; Shi Z; Li Y; Zhu G; Chen C; Zhang Z; Shi R; Su L; Cao P; Pan Z; Zhang H; Liu M; Liu H; Chen J
Front Oncol; 2022; 12():850943. PubMed ID: 35311148
[TBL] [Abstract][Full Text] [Related]
16. A Prognostic Pyroptosis-Related lncRNAs Risk Model Correlates With the Immune Microenvironment in Colon Adenocarcinoma.
Xia F; Yan Y; Shen C
Front Cell Dev Biol; 2021; 9():811734. PubMed ID: 34966747
[TBL] [Abstract][Full Text] [Related]
17. Pyroptosis-Related lncRNAs for Predicting the Prognosis and Identifying Immune Microenvironment Infiltration in Breast Cancer Lung Metastasis.
Liu L; Chen C; Tu G; Peng Y; Shen M; Xu Y; Liu S
Front Cell Dev Biol; 2022; 10():821727. PubMed ID: 35309942
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and Immune Implications of a Novel Pyroptosis-Related Five-Gene Signature in Breast Cancer.
Zheng Y; Wang K; Li N; Zhang Q; Chen F; Li M
Front Surg; 2022; 9():837848. PubMed ID: 35656090
[TBL] [Abstract][Full Text] [Related]
20. Effect of Pyroptosis-Related Genes on the Prognosis of Breast Cancer.
Zhou Y; Zheng J; Bai M; Gao Y; Lin N
Front Oncol; 2022; 12():948169. PubMed ID: 35957895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
